Volver a Agenda
Session Chair(s)
Barry Berger, JD, MBA
Retired
Former Professor of Regulatory Affairs, Temple University, United States
Learning Objective : Discuss if there is a need for FDA or other government agencies to play more of an enforcement role; Discuss if the Responsible Corporate Officer doctrine represents good public policy; Identify what other enforcement actions have been and are being taken by regulators that impact industry and the public; Discuss recent False Claims and Whistleblower actions; Discuss the significance of the Foreign Corrupt Practices Act.
Speaker(s)
Panelist
Adolfo R. Garcia, JD
Brown Rudnick, United States
Partner
Panelist
Susan G. Winkler
US Attorney's Office, District of Massachusetts, United States
Assistant US Attorney
¿Tiene una cuenta?